Abstract
Fluoroquinolones have been associated with peripheral sensory disorders and weakness, especially in patients with underlying myasthenia gravis or myasthenia-like Eaton-Lambert syndrome. Trovafloxacin is a relatively new quinolone for which these side effects have not been described. We report a case of diffuse weakness due to a demyelinating polyneuropathy that began after initiation of trovafloxacin in a patient without an underlying neurologic disorder.
| Original language | English |
|---|---|
| Pages (from-to) | 514-515 |
| Number of pages | 2 |
| Journal | Southern Medical Journal |
| Volume | 93 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2000 |
| Externally published | Yes |